The association between gastric body-fundus carcinoids and autoimmune bodyfundus (type A) chronic atrophic gastritis (CAG) with hypergastrinemia is well documented [1] [2] [3] [4] [5] . The recent detection of Helicobacter pyloni (HP) antibodies in serum of elderly people with type A CAG [6] as well as the progressive evolution of some antrum-body (type AB) pangastritis into A-type CAG [7] suggest that endstage HP-related type A CAG may also contribute to carcinoid development. In addition, there have been reports of carcinoids arising in non-CAG gastric mucosa, either with hypergastrinemia and multiple endocrine neoplasia/Zollinger-Ellison syndrome (MEN/ZES) [8] or without hypergastrinemia [4,9-111. 
cancer of "intestinal" (i.e., glandular) type is well documented [12] [13] [14] . Follow-up studies have outlined the increased cancer risk inherent to CAG and IM [15] , although intestinal phenotypes were not more frequent in CAG/IM associated glandular cancers than in CAG/IM unrelated diffuse cancers [16, 17] . In addition, both serological prospective [18, 19] and histological retrospective studies [20, 21] have found HP infection, with resultant chronic gastritis, to be positively associated with gastric cancer, either of intestinal or diffuse histology.
In this paper, non-tumor mucosa from patients with and without gastric carcinoids, neuroendocrine carcinomas, or early cancers has been investigated for distinctive patterns of tumor-associated gastritis. Attention specifically focused on HP colonization and gastritis activity, atrophy, or topography as possible factors in tumorigenesis.
MATERIALS AND METHODS
Histologic material and clinical records of all the 60 gastric endocrine tumors (mean age, 52 years; 32 males, 28 females) available in the files of our departments due to personal observation or consultation were reinvestigated. Histologic sections from tumor tissue and non-tumor mucosa were stained with hematoxylin-eosin, Grimelius' silver impregnation for argyrophil cells, periodic acid-Schiff (PAS)-alcian blue pH 2.5, high-iron diamine (HID), and periodic acid-concanavalin A (PACO-NA) techniques for mucins, as well as Giemsa stain for Helicobacterpylori [17, 22] . Immunoperoxidase tests for chromogranin A, sterotonin, gastrin, somatostatin, pancreatic polypeptide, enteroglucagon, epithelial membrane antigen (EMA), pepsinogen II, Ml antigen of gastric surface mucin, CAR-5 intestinal antigen, HLA-DR antigen, L26 B lymphocyte antigen, and UCHL1 T-lymphocyte antigen were carried out as reported elsewhere [8, 17, 21, 23, 24] .
Non-tumor mucosa from a surgical series of 150 early gastric cancers (EGCa; mean age, 63.2 years), an endoscopic series of 1,177 unselected tumor-free patients (mean age, 53.7 years), and 58 endoscopic tumor-free A-CAG were systematically investigated for HP and gastritis status according to previously reported criteria [24] . The EGCa series was collected during the years 1979-1991 in the Pavia and Varese sections of our department, while the unselected non-tumor series included all the patients undergoing endoscopy at the Endoscopic Unit of Pavia II Medical Clinic in the period 1987-1991 with diagnosis of active (228 cases) or healed (269) peptic ulcer, non-ulcer dyspepsia (631), or various non-gastric symptoms (49). The 58 A-CAG cases resulted from the addition of all the 42 cases observed in Varese, during the years 1979-1991, to the 16 cases found among the Pavia unselected series.
The chi-squared test was used for statistical analysis.
RESULTS

Gastntis and Endocrine Tumors
Tumor Histology The 60 cases of gastric endocrine tumors were classified, as reported in Table 1 , based on their histology ( Fig. 1) and on previously reported criteria [1] [2] [3] [4] [5] 25, 26] . They [26] .
All carcinoids were histologically well differentiated, intensely chromogranin A-immunoreactive, argyrophil but not argentaffin, thus fullfilling the criteria for their diagnosis as enterochromaflin-like (ECL)-cell argyrophil carcinoids [2] [3] [4] [5] 9, 11, 25, 26] . They arose in the fundus (sometimes involving cardial mucosa), corpus, or transition between corpus and antrum, especially in the angular region.
Neuroendocrine [10, 22, 23] . In addition, close association of carcinoid with apparently hyperplastic growth of foveolar cells was frequently observed (Fig. 1) .
Associated Gastritis The histology of non-tumor gastric mucosa, with special reference to gastritis status and colonization by Helicobaterpylori, has been outlined in Table 1 Five of ten carcinoid patients with HP-negative type A CAG in whom pertinent hematologic investigations were performed showed pernicious anemia (PA). In another HP-negative A-CAG case showing corpus-fundus carcinoids and NEC, megaloblastic anemia developed five years after proximal gastric resection. Only one of 11 HP-positive CAG cases (seven of which were type A) with various kinds of tumors showed PA. In addition to type A CAG, this patient also had circulating anti-parietal cell antibodies as well as autoimmune thyroiditis. The class II histocompatibility antigen HLA-DR was abundantly expressed in non-endocrine epithelia of both HP-negative and HP-positive CAG mucosa. No HLA-DR antigen was detected in adjacent endocrine growths, however, either hyperplastic or dysplastic and neoplastic.
HP-negativeA-CAG cases with PA ( Fig. 2) were characterized by diffuse, total, or at least subtotal atrophy of acidopeptic glands, with disappearance of mature parietal and chief cells coupled with hyperplasia of immature, basophilic, PGI-, PGII-, and PACONA-positive mucous neck cells (so-called pseudopyloric metaplasia) [22] . Deep, multifocal pyloric-type metaplasia (PGII-and PACONA-positive, but PGInegative) with or without gastrin-immunoreactive G cells, more or less extensive intestinal metaplasia of small intestine (I) type, and more or less prominent foveolar hyperplasia with or without hyperplastic polyps were also found. Abundant inflammatory cells were observed in the lamina propria of deep and mid mucosa, with relative prevalence of lymphocytes (both B and T cells) over plasma cells, especially around immature mucous-neck glands with evidence of epithelial aggression and damage. Neutrophilic granulocytes were found only occasionally at sites of non-HP bacterial colonization of superficial mucosa. The antropyloric mucosa was either entirely normal or with mild, superficial, inactive gastritis and no epithelial damage or metaplastic change.
HP-positive CAG cases (Fig. 3) showed an abundance of plasma cells in the superficial half of the corpus fundus mucosa, with or without few neutrophilic granulocytes, abundance of lymphocytes (especially B cells in follicles, both B and T cells diffusely in the lamina propria) in the deep half, often coupled with fairly abundant eosinophils, mast cells, and macrophages. All 11 cases had HP colonization of inflamed corpus fundus mucosa, while only two of nine cases tested had antral mucosa colonization. Surviving areas or small groups of acidopeptic glands with mature parietal and chief cells, in addition to mucous-neck and transitional mucousneck/chief cells [27] , were found in all cases, especially in proximal fundus mucosa. Immature mucous-neck cell hyperplasia was less prominent, while intestinal metaplasia, partly of incomplete (II or III) type, was more abundant than in HP-negative PA cases. Antropyloric mucosa of cases with HP-positive corpus fundus CAG was characterized by various grades of chronic gastritis, from atrophic with intestinal metaplasia (AB-type CAG, two cases) to HP-positive interstitial-follicular type with relatively scarce activity and abundant plasma cells and B lymphocytes (one case), or HP-negative type with mild inflammation, often associated with myofibroblast proliferation in the mild and deep lamina propria (six cases). The latter pattern probably results from healing of antritis coupled with progression of atrophic corpus gastritis, a relatively frequent observation in older patients with chronic HP gastritis [6, 7, 24] .
Gastritis and Early Cancer
As outlined in percent of type AB, 50 percent of type A, and 100 percent of common gastritis, with slightly higher incidence in the antral mucosa for the last group and more obvious predominance in the corpus mucosa for the other groups.
As many as 88 percent of cases showed intestinal metaplasia in peritumor mucosa, 80 percent in antral mucosa, and 30 percent in corpus mucosa. Type III (sulfomucinpositive) intestinal metaplasia was detected in 56 percent of cases. Intestinal metaplasia as a whole and type III metaplasia were three to five times more abundant in stomachs with glandular cancer than in those with diffuse cancer.
Tumor-Free Gastritis CAG was present in 264 patients (22.4 percent), including 12.8 percent type B, 8.2 percent type AB, and 1.4 percent type A, while 790 subjects (67.1 percent) had non-atrophic gastritis and 123 (10.5 percent) gastritis-free mucosa. The incidence of CAG as a whole was significantly lower (p <0.001) than that of cancer, carcinoid, or endocrine tumor patients. By itself, the ten to 11 years' greater age of cancer patients, with respect to tumor-free patients, would correspond to a marginal, non-significant increase of CAG incidence from 22 to 28 percent in the latter population. A-CAG incidence was obviously higher (p <0.001) in endocrine tumor or carcinoid (but not cancer) cases than in tumor-free cases, while the incidence of both B-and AB-CAG was higher in cancer than in tumor-free cases (p < 0.001), and that of B-CAG was lower in endocrine tumor than in tumor-free cases (p < 0.05). HP colonization was found in 95 percent of type B, 76 percent of type AB (p < 0.001 versus type B), 31 percent of type A (p < 0.001 versus type B as well as versus type AB), 90 percent of non-atrophic gastritis (p < 0.001 versus type AB as well as type A), and none of gastritis-free cases. No significant difference was observed with respect to corresponding gastritis groups of cancer or endocrine tumor patients.
Intestinal metaplasia (mostly type I) was observed in 25 percent of antral biopsies and 7 percent of corpus biopsies. Both figures were significantly lower (p < 0.001) than those observed in cancer patients as a whole or in glandular cancer cases. Combined antrum + corpus incidence of IM was near 0 percent in gastritis-free cases, 20 percent (extension about 5 percent) in common non-atrophic gastritis, 63 percent (antral extension about 30 percent) in type B, 70 percent (extension about 20-30 percent) in type AB, and 81 percent (corpus extension about 30 percent) in type A CAG.
Selected A-CAG Cases Among the 58 A-CAG cases, 11 (19 percent) showed HP colonization, which involved corpus mucosa in all cases and antral mucosa in seven cases. Ten of the 11 HP-positive cases showed a pattern of corpus gastritis characterized by residual acidopeptic glands, abundant plasma cells, granulocytes, and intestinal metaplasia (present in seven cases; mean extension, 30 percent of the mucosa), thus mimicking the HP-positive A-CAG associated with endocrine tumors, apart from increased activity. Forty-three of the 47 HP-negative cases showed a severe diffuse pattern of oxyntic gland atrophy with lack of mature acidopeptic glands, abundant pyloric/pseudopyloric metaplasia (covering about 50 percent of the glandular compartment, as against 20-30 percent in the former group), fewer plasma cells and granulocytes, and less extensive intestinal metaplasia (present in 20 of the 43 cases, covering less than 10 percent of the mucosa as a mean), thus mimicking "autoimmune" A-CAG of endocrine tumor patients. Pernicious anemia was detected in 11 of the 35 cases (31 percent) from which hematologic data were available. All PA cases were HP-negative and showed the "autoimmune" type of A-CAG with diffuse gland atrophy.
DISCUSSION
Most gastric endocrine tumors investigated were from body-fundus or transitional body-antrum mucosa (95 percent) and showed morphological patterns of argyrophil carcinoids (73 percent), usually with ECL cells as a prominent component [4, 10, 26] .
Twenty-three of 44 (52 percent) argyrophil carcinoids arose in a background of severe corpus fundus (type A) atrophic gastritis, coupled with achlorhydria-related hypergastrinemia, while three (7 percent) showed CAG of type not assessed.
Interestingly, hypergastrinemia has been observed in all A-CAG patients with carcinoids so far investigated [2] [3] [4] [5] 11, 26] , suggesting that both advanced A-CAG and the resulting hypergastrinemia are essential in the development of body fundus argyrophil carcinoids with very low malignant potential [26] . A crucial role of hypergastrinemia in the genesis of gastric argyrophil ECL-cell carcinoids has been conclusively shown in aged achlorhydric rats [28] . Circulating anti-parietal cell antibodies impairing acidopeptic gland maturation and function [29] [30] [31] as well as HLA-DR-mediated autoimmune aggression to non-endocrine gastric epithelia, with special reference to mucous-neck cells, may account for the severe atrophy of acidopeptic glands in autoimmune type A CAG, often associated with pernicious anemia. The incomplete pattern of gland atrophy (frequently leaving patchy areas of surviving glands with mature parietal and chief cells) that we observed in most HP-positive A-CAG cases may explain their failure to develop pernicious anemia.
Composite tumors showing an intimate admixture of endocrine and exocrine cells, as in two of our cases, suggest that some body fundus endocrine tumors may originate from neoplastic transformation of pluripotent epithelial stem cells that retain some capacity of dual, endocrine, and non-endocrine differentiation [32] . Stem-cell growth seems also involved in the histogenesis of neuroendocrine carcinomas which, in addition to undifferentiated and poorly differentiated endocrine cells, often show more or less prominent non-endocrine glandular or even squamous components [10, 33] .
The co-existence of topographically separate endocrine and exocrine tumors (as in three of our cases) can be explained by their sharing of some risk factor or condition. Indeed, pernicious anemia patients with A-type CAG are known to be at increased risk for both carcinoids and cancer [34] . Gastrin, a growth factor for ECL cells [35] and related tumors [28] , as well as for epithelial stem cells in the oxyntic mucosa [35] , might have a role in the pathogenesis of both endocrine and exocrine tumors arising in the corpus fundus, possibly by acting in combination with other factors released locally during chronic inflammation, such as some prostaglandins [36, 37] and lymphokines [38] [39] [40] known to modulate both endocrine and exocrine gastric epithelia. This hypothesis would also explain the frequent, intimate association of foveolar hyperplasia, known to be promoted by prostaglandin E2 (PGE2), and underlying carcinoids.
As for ordinary gastric cancer, it must be recalled that oxyntic gland cell lines are only seldom found in such tumors, where gastrin-independent intestinal and pyloric lines largely predominate [16, 17, 23, 41] . In fact, hypergastrinemia seems to inhibit rather than stimulate pyloric carcinogenesis, providing mucosal contact with acid juice is preserved [43] , while its role in intestinal carcinogenesis is controversial [44, 45] .
The high incidence of HP colonization in stomachs with early cancer (84 percent, p < 0.001 versus carcinoids) was in the same range as that found in simultaneously investigated gastric (93 percent) or duodenal (96 percent) ulcers, two wellestablished HP-related diseases, and in non-ulcer dyspepsia (73 percent), also known to be in part related to HP gastritis [24] , while it differed significantly (p < 0.001) from that of subjects free of gastric symptoms (55 percent). Thus, our colonization findings further support the hypothesis suggested by serologic studies, combined with epidemiologic [46] and prospective investigations [18, 19] , that HP infection may represent a major risk factor for gastric cancer. The fact that diffuse cancer, unrelated to intestinal metaplasia [13, 21] , has even higher HP colonization (100 percent versus 74 percent, p < 0.001) and HP-related risk [19] than does metaplasia-related "intestinal" cancer suggests that, in addition to the carcinogenetic pathway leading from CAG to intestinal metaplasia and dysplasia [12] [13] [14] , another mechanism also contributes to the HP-related risk. It seems possible that the active inflammation observed at foveolar neck level of EGCa patients causes oxidative stress to generative zone epithelia as well as increased proliferation and topographic expansion of the epithelial stem cells, up to superficial epithelia exposed to environmental carcinogens [21] . Direct interaction of lumen-contacting cells retaining proliferative potential and endoluminal carcinogens has already been shown to be crucial in rat carcinogenesis [47] .
HP incidence was very low in both CAG-associated (21 percent) and CAGunrelated (20 percent) carcinoids, and similar to that of tumor-free A-type CAG (19 percent). Moreover, carcinoid-associated gastritis was usually inactive or poorly active, even when HP-positive. As discussed above, other factors, unrelated to HP and intestinal metaplasia, must be involved in carcinoid pathogenesis.
In conclusion, it seems likely that, despite the occurrence of HP in a small proportion of stomachs bearing endocrine tumors, active HP gastritis has little role in the pathogenesis of gastric argyrophil carcinoids. The hypergastrinemia-producing type A CAG, be it purely autoimmune or end stage of HP gastritis, when found in association with carcinoids, is as a rule inactive; that is, devoid of granulocytes. On the contrary, active HP gastritis seems to have a major role in the pathogenesis of gastric cancer, leading preferentially to glandular cancer in a background of type AB or B CAG, coupled with extensive intestinal metaplasia (especially of type III), and to diffuse cancer in the presence of type B CAG or non-atrophic gastritis without type III metaplasia, with or without moderately developed type I metaplasia.
